Jordan vs New Zealand: Treatment success rate for patients treated for MDR-TB
Jordan
100.0%
in 2022
New Zealand
100.0%
in 2022
Jordan rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Jordan
- New Zealand
How they compare
Jordan currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 8 times across 17 shared years of data; in 2002 it was New Zealand ahead.
Jordan ranks 1st and New Zealand ranks 1st of 163 countries.
Across the 3 decades both report, Jordan averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | Jordan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.8% | 48.2% | 13.5% | Jordan |
| 2010s | 71.3% | 66.6% | 4.7% | Jordan |
| 2020s | 77.7% | 100.0% | 22.3% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Jordan or New Zealand?
- Jordan, at 100.0% against 100.0% in New Zealand as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Jordan and New Zealand?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and New Zealand?
- 17 years are reported by both, from 2002 to 2022.
- How do Jordan and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Jordan ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.